| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/31/2002 | CN1361257A New polypeptide NAD dependent 2-hydroxy acid dehydrogenase family protein 19.91 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361256A New polypeptide pyrroline-5-carboxylic reductase 10.23 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361255A New polypeptide human dioxygenase 9.13 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361254A New polypeptide acyl CoA dehydrogenase 12.65 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361253A New polypeptide human aldehyde/ketone reductase 9.46 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361252A New polypeptide hydrogenase 36.08 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361251A New polypeptide hydrogen peroxide redox enzyme 13.86 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361250A New polypeptide human short-strand dehydrogenase 9.46 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361249A New polypeptide NADH dehydrogenase subunit I-9.46 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361248A New polypeptide human serine-tRNA synthetase 56.65 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361247A New polypeptide DNA polymerase III 41.36 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361246A New polypeptide formamidopyrimidine-DNA glycosylase 11.77 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361245A New polypeptide histidyl-tRNA synthetase 13.09 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361181A New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 07/31/2002 | CN1361180A New polypeptide corticotrophin releasing factor 8.8 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361178A New recombinant blood coagulation factor VIII and its production process and medicinal composition |
| 07/31/2002 | CN1360946A Medicinal composition containing rummyfudin and transfer factor |
| 07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
| 07/31/2002 | CN1360889A Externally applied medicine for women's wedding night |
| 07/31/2002 | CN1360833A Prepn for earthworm antibacterial peptide |
| 07/31/2002 | CN1088472C Nereid kinase and its extraction method and use |
| 07/31/2002 | CN1088456C Substituted oxazolidine calpain and/or cathepsin B inhibitors |
| 07/30/2002 | US6426411 PGC-1, a novel brown fat pparγ coactivator |
| 07/30/2002 | US6426403 TRAF family molecules, polynucleotides encoding them, and antibodies against them |
| 07/30/2002 | US6426402 Respiratory system disorders; rheumatic diseases |
| 07/30/2002 | US6426401 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 07/30/2002 | US6426367 Methods for selectively occluding blood supplies to neoplasias |
| 07/30/2002 | US6426361 Method and compositions for increasing the anaerobic working capacity in tissues |
| 07/30/2002 | US6426341 Treatment for diabetic complications |
| 07/30/2002 | US6426336 Method for treating allergic lung disease |
| 07/30/2002 | US6426335 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 07/30/2002 | US6426334 Administering nucleotide sequence |
| 07/30/2002 | US6426332 Osteogenic protein is provided alone or dispersed in a biocompatible non-rigid, amorphous carrier having no defined surfaces |
| 07/30/2002 | US6426331 Inhibitors of STAT function |
| 07/30/2002 | US6426330 Active materials; genetic engineered polypeptide |
| 07/30/2002 | US6426329 Reduction of side effect of cyclosporin a |
| 07/30/2002 | US6426222 Incubation tissue cells in liquid nutrients |
| 07/30/2002 | US6426221 Polynucleotide |
| 07/30/2002 | US6426220 Antisense modulation of calreticulin expression |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426210 Storage of materials |
| 07/30/2002 | US6426209 Mammalian heparanase protein |
| 07/30/2002 | US6426208 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 07/30/2002 | US6426206 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/30/2002 | US6426205 Methods and compositions for modulating ubiquitin dependent proteolysis |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |
| 07/30/2002 | US6426198 Genes for Niemann-Pick type C disease |
| 07/30/2002 | US6426191 Assays involving an IL-1 receptor antagonist |
| 07/30/2002 | US6426188 Antisense modulation of phosphorylase kinase alpha 1 expression |
| 07/30/2002 | US6426187 Transfection using rna polymerase |
| 07/30/2002 | US6426099 Herbal formulation for rebuilding intestinal bacteria |
| 07/30/2002 | US6426094 Method of enhancing the efficacy of anti-tumor agents |
| 07/30/2002 | US6426085 Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
| 07/30/2002 | US6426076 Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy |
| 07/30/2002 | US6426075 Genetic engineered polypeptide; killing cancer cells |
| 07/30/2002 | US6426073 Genetic engineered polypeptides |
| 07/30/2002 | US6426071 Administering protein c |
| 07/30/2002 | US6426070 Using eosinophil ribonuclease |
| 07/30/2002 | US6426069 Method and compositions for increasing intestinal absorption of fats |
| 07/30/2002 | US6426068 Prevent cell or organ degradation; plant extracts |
| 07/30/2002 | US6425881 Therapeutic mixture useful in inhibiting lesion formation after vascular injury |
| 07/30/2002 | US6425769 Genetic engineering |
| 07/30/2002 | CA2369405A1 Har a polypeptides and nucleic acids, and related methods and uses thereof |
| 07/30/2002 | CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 07/30/2002 | CA2268433C Improved interferon polymer conjugates |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2226293C Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/30/2002 | CA2160543C Methods and compositions for delaying or preventing the onset of autoimmune disease |
| 07/30/2002 | CA2072081C Polyhemoglobin stabilized by purine derivatives and glutathione |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/30/2002 | CA2039230C Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
| 07/25/2002 | WO2002058323A2 Method for identifying modulators of bace |
| 07/25/2002 | WO2002057795A2 Methods of diagnosis and treatment of osteoporosis |
| 07/25/2002 | WO2002057779A2 Cloning and expression of a new mcp receptor in glial cells |
| 07/25/2002 | WO2002057566A2 Method for identifying compounds modulating sister chromatid separation |
| 07/25/2002 | WO2002057484A2 Method and test system for identifying substances which protect nerve cells |
| 07/25/2002 | WO2002057480A2 Cell-proliferative disorder treatments using cre decoy oligomers, bcl-2 antisense and hybrid oligomers |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057458A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/25/2002 | WO2002057457A2 Human proteins 55562 and 21617, and methods of use thereof |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057452A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | WO2002057450A2 Proteins and nucleic acids encoding same |
| 07/25/2002 | WO2002057444A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/25/2002 | WO2002057440A2 Screens and assays for agents useful in controlling parasitic nematodes |
| 07/25/2002 | WO2002057436A2 Red blood cell from a transgenic animal as vehicle for polypeptide delivery |
| 07/25/2002 | WO2002057435A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 07/25/2002 | WO2002057427A2 Mammalian tumor susceptibility gene products and their uses |
| 07/25/2002 | WO2002057425A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 07/25/2002 | WO2002057421A2 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/25/2002 | WO2002057420A2 50 human secreted proteins |
| 07/25/2002 | WO2002057419A2 Protein-protein interactions |
| 07/25/2002 | WO2002057415A2 Method for altering cell fate |
| 07/25/2002 | WO2002057413A2 Peptides for activation and inhibition of delta pkc |
| 07/25/2002 | WO2002057409A2 Antisense modulation of src-2 expression |
| 07/25/2002 | WO2002057408A2 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 07/25/2002 | WO2002057366A1 Impact modified polyamide composition |
| 07/25/2002 | WO2002057314A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 07/25/2002 | WO2002057309A1 Novel g protein-coupled receptor protein and dna thereof |